CDP

Dược phẩm Trung ương Codupha ·UPCOM ·2026Q1

● Maintaining

Price
13,000
Latest close
04 Jun 2026
P/E 7.63x
P/B 1.01x
EPS 1,703
BVPS 12,906
ROE 13.6%
ROA 1.4%
Profit Margin 1.0%
Asset Turnover 1.39x
Equity Mult. 10.01x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, CDP has not moved the needle on revenue, but profitability has edged up slightly — margins have been expanding consistently over multiple periods. Notably, operating cash flow is significantly negative relative to profit — this needs monitoring in coming periods.

TTM REVENUE
VND 3,195bn
−2.9%YoY
NET MARGIN
0.97%
+0.3ppYoY
TTM NET PROFIT
VND 31bn
+39.9%YoY
CFO / Net Income
-3.65x
negative cash flow vs profit
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 598.0 1,041.4 767.3 788.7 685.9 973.0 667.3 964.4 604.8 1,035.3 646.3 736.7
Growth -43% +36% -3% +15% -30% +46% -31% +59% -42% +60% -12%
Net Income 8.5 8.8 9.1 4.8 6.1 2.9 6.1 7.1 3.4 1.7 3.4 7.7
Net Margin 1.42% 0.84% 1.18% 0.61% 0.89% 0.30% 0.92% 0.74% 0.57% 0.16% 0.53% 1.04%

Drivers of CDP's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by lower administrative expenses. Supporting and offsetting drivers:

Administrative expenses ↓ 21.5bn
Financial income ↑ 6.2bn
Tax ↓ 2.1bn
Gross profit ↓ 13.0bn
Selling expenses ↑ 5.0bn
Finance costs ↑ 4.5bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 12.6bn
Administrative expenses ↓ 6.0bn
Finance costs ↑ 6.5bn
Financial income ↓ 5.6bn
Selling expenses ↑ 3.7bn
Tax ↑ 0.5bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 10.2% = 0.7% × 1.54 × 9.76
2026Q1 13.6% = 1.0% × 1.39 × 10.01

ROE rose from 10.2% to 13.6% — mainly driven by leverage, despite asset turnover moving in the opposite direction.

Net margin: 1.0% +0.3pp Asset turnover: 1.39x -0.15x Leverage: 10.01x +0.24x

Is the profit sustainable?

Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.

very positive positive stable watch under pressure

What is driving the margin?

Net margin stands at 0.97%, broadly flat versus the same period. Supportive factors and pressure points are offsetting one another.

Margin is nearly flat but the underlying components are moving — this is a transitional phase, more time is needed to see the real trend.

Profitability trend

Net Margin 0.97% +0.3pp
Gross Margin 6.94% −0.2pp
SG&A / Revenue 5.04% −0.4pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Is capital being deployed efficiently?

ROIC edged up to 2.66%, rising 0.5pp. That translates to 2.66 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 0.3pp, with capital turnover fell 0.46x; while invested capital rose by 139bn.

NOPAT margin is the main cushion preventing ROIC from slipping as invested capital keeps expanding — the quality of this improvement depends on whether margin holds once the new capital is fully deployed.

Watchpoints

ROIC remains low

ROIC is currently 2.66% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 2.66% +0.5pp
NOPAT Margin 0.97% +0.3pp
Capital Turnover 2.73x −0.46x
Average Invested Capital 1,168.9bn +138.8bn

Balance Sheet

Leverage is very high, with clear pressure on the capital structure — liabilities at 9.60x equity, net debt at 4.27x equity.

Inventory ended the period at 944.9bn, roughly 39.1% of total assets.

Over the last 12 months, working capital absorbed 185.9bn of cash, mainly because of higher receivables and higher inventories. Part of that drag was offset by higher payables.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −179.0bn
Inventories increased → lower CFO: −88.1bn
Payables increased → higher CFO: +81.2bn

Working Capital Efficiency

Cash conversion cycle lengthened by 21.3 days versus the same period last year. The main moves came from DIO rose 5.1 days, DSO rose 22.1 days, and DPO rose 5.9 days.

Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 109.4 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +22.1 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 125.5 days +22.1 days
Inventory 115.2 days +5.1 days
Payables 131.3 days +5.9 days
Cash Conversion Cycle 109.4 days +21.3 days

Is financial risk significant?

High leverage combined with negative operating cash flow — this area needs close monitoring.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at 4.27x and interest coverage only at 0.64x.

At present, short-term debt accounts for 97.2% of total debt, cash equals 1.7% of debt, and total debt stands at 1,023.3bn.

Watchpoints

Net leverage is elevated

Net debt / equity stands at 4.27x, increasing balance-sheet pressure.

Interest coverage is thin

Interest coverage is 0.64x, leaving limited room to absorb financing costs.

Leverage and liquidity trend

Net Debt / Equity 4.27x +0.36x
Interest Coverage 0.64x +0.06x
Cash / Debt 1.7% +0.7pp
Short-term Debt / Total Debt 97.2% +0.5pp
CFO / NI -3.65x +1.25x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

High leverage combined with cash flow below reveals the actual liquidity pressure. Operating cash flow reached -91.0bn in 2025, against investing cash flow of 5.0bn.

Post-investment cash flow was negative +86.0bn. Financing cash flow was positive +95.0bn.

CFO / net income was -3.65x.

After spending +1.5bn on fixed-asset investment, the business generated trailing free cash flow of −115.1bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 113.7bn −4.7bn
Cash Capex 1.5bn
FCF TTM −115.1bn

Investment Takeaway

The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. The brighter spot is earnings conversion is confirmed, with CFO/NI at -3.65x. The main risk still sits in capital efficiency remains weak, with ROIC at 2.7%.

Improvement: earnings conversion looks more confirmed, with CFO / net income at -3.65x.

Key risk: Capital efficiency remains weak.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
3,285.3 3,208.7 3,064.0 3,045.9 2,450.4
Cost of Goods Sold
3,068.4 2,972.8 2,854.1 2,835.1 0.0
Gross Profit
216.9 235.9 210.0 210.8 164.1
Financial Expenses
54.9 58.6 60.9 46.8 -37.2
Selling Expenses
119.2 126.1 115.9 121.8 -96.7
General and Administrative Expenses
40.4 49.9 54.7 47.0 -33.3
Operating Profit
40.6 27.7 15.9 28.9 22.0
Profit Before Tax
40.8 27.2 13.9 28.9 22.6
Net Income
35.4 19.1 9.2 23.2 18.0
Profit Attributable to Parent
35.4 19.1 9.3 23.1 18.0
Earnings per Share
1,669.00 773.00 384.00 1,051.00 984.94

Explore Other Stocks In The Same Sector

DP1, TTD, JVC, YTC, TNH

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.